EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Assessing the clinico‐immunological profile of patients with obesity and chronic rhinosinusitis

Mohamad R Chaaban, Kewal Asosingh, Suzy Comhair, David Hoying

International Forum of Allergy & Rhinology · 2024

DOI: 10.1002/alr.23304 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Mohamad R Chaaban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Obesity, Cytokines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: American Rhinologic Society Friends in Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

No studies have investigated the systemic and local sinonasal profile of obesity‐related chronic rhinosinusitis (CRS), despite its observed association in recent retrospective studies. The objectives of our study were to assess the impact of obesity on the clinical and cytokine profile of patients with CRS and evaluate treatment response with functional endoscopic sinus surgery.

Methods

This was a prospective observational study at the Cleveland Clinic that included patients with CRS ( n = 54) between December 2021 and September 2022. Data collection included demographics, body mass index (BMI), comorbidities, baseline sinonasal outcome test scores, baseline radiologic scores (Lund–Mackay), postoperative sinonasal outcome test scores (at 3–4 months), and local and systemic alarmins/T‐helper cytokines.

Results

Out of the 54 CRS patients, there were 20 CRS patients without nasal polyps (37%) and 34 with nasal polyps (63%). Patients were categorized based on obesity (BMI ≥ 30 kg/m 2 ). Obese CRS patients had lower systemic alarmins (interleukin [IL]‐33 and Thymic stromal lymphopoietin (TSLP)) compared to non‐obese CRS patients (IL‐33: 744.2 ± 1164.6 pg/mL vs. 137.5 ± 320.0 pg/mL, p = 0.005; TSLP: 627.7 ± 1806.3 pg/mL vs. 28.1 ± 85.4 pg/mL, p = 0.017). CRS patients with nasal polyps with BMI ≥30 kg/m 2 had higher postoperative sinonasal outcome test scores and lower levels of nasal eotaxin‐3 and IL‐33 compared to BMI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisObesityCytokinesNasal PolypsHumansMaleFemaleMiddle AgedChronic DiseaseAdultProspective StudiesAgedInterleukin-33EndoscopyThymic Stromal LymphopoietinChemokine CCL26Rhinosinusitis

Stichwörter der Autor:innen

chronic rhinosinusitiscytokinesobesity

Substanzen

CytokinesInterleukin-33Thymic Stromal LymphopoietinIL33 protein, humanTSLP protein, humanChemokine CCL26

Autor:innen und Institutionen

  • Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Förderung

  • American Rhinologic Society Friends in Research Grant

Zitieren

APA

Chaaban, M. R., Asosingh, K., Comhair, S., & Hoying, D. (2024). Assessing the clinico‐immunological profile of patients with obesity and chronic rhinosinusitis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23304

Vancouver

Chaaban MR, Asosingh K, Comhair S, Hoying D. Assessing the clinico‐immunological profile of patients with obesity and chronic rhinosinusitis. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23304

BibTeX
@article{Chaaban2024,
  author = {Chaaban, Mohamad R and Asosingh, Kewal and Comhair, Suzy and Hoying, David},
  title = {Assessing the clinico‐immunological profile of patients with obesity and chronic rhinosinusitis},
  journal = {International Forum of Allergy & Rhinology},
  year = {2024},
  doi = {10.1002/alr.23304}
}
Kostenlos starten →